-
Acorda loses Nasdaq listing to cap biotech’s end
16 Apr 2024 16:27 GMT
… the twilight zone. The biotech’s closure date is set … Acorda saw success with its drugs for neurological disorders. Inbrija ( … ) — also marketed as Fampyra (fampridine) outside of the US — were … is the parent company of Pharmaceutical Technology.
Access the most …
-
Human medicines European public assessment report (EPAR): Fampridine Accord, fampridine, Date of authorisation: 24/09/2020, Revision: 2, Status: Authorised
11 Apr 2024 11:43 GMT
For the body’s muscles to contract, electrical impulses are transmitted along the nerves to the muscles. In MS, this transmission of electrical impulses is impaired when the covering around the nerves become damaged, which can lead to muscle weakness, …
-
Patient's anger as hundreds miss out on medication
15 Feb 2024 08:17 GMT
… the road,” she said.
Despite fampridine being approved more than four … offer it, despite new medicines generally being offered within 60 … 500 patients eligible for this treatment in its area.
Ms … relation to the introduction of fampridine in our health board …
-
Health board still not providing patients with treatment five years after it was first approved
15 Feb 2024 02:26 GMT
… drug, fampridine, was approved by the Welsh Government as an NHS-funded treatment … Morris, said: "Newly approved medicines should be offered within 60 … to this potentially life improving medication.” The Ombudsman has recommended that …
-
Biogen ends agreement with Acorda for multiple sclerosis drug Fampyra
11 Jan 2024 19:46 GMT
… Therapeutics for the multiple sclerosis drug Fampyra.
Acorda will have the … drug in-house effective Jan. 1, … drug is marketed as Fampyra (fampridine) in the EU as a treatment to …
-
Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options – Review Article
20 Nov 2023 04:35 GMT
… and 107 clinical trials. Only English-language … -β (INF-β) and vaccinations are connected to fatigue through … nocturia and medication effects. In addition, some medications could change … observed with fampridine and with non-pharmacological treatment, such …
-
Fampridine product-specific bioequivalence guidance
22 Jun 2023 19:36 GMT
For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.
-
Revenue for Nusinersen by Biogen is expected to have a CAGR of -16.2% through 2038. How does that impact the rNPV of the drug?
30 Dec 2022 07:47 GMT
… is involved in 18 clinical trials, of which 8 were completed … -release fampridine tablets), and Plegridy (peginterferon beta-1a) for the treatment of … .
Quick View – Nusinersen
Report Segments
Drug Name
Administration Pathway
Therapeutic Areas …
-
Disabled Grimsby man forced to choose between medication and care as cost of living soars
22 Nov 2022 17:54 GMT
… Mr Pridgeon, who is medically retired and receives Personal Independence … month on the drug fampridine, a symptom management treatment for MS … was housebound before the trial but by the end … travelling to doctors appointments. “I went without fampridine for a …
-
The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis
05 Nov 2022 20:39 GMT
… pharmaceutical database [collecting data on prescription of drugs … single institution, department, doctor, individual, or individual … M03BX01) for spasticity; fampridine (ATC code N07XX07) … pharmacological treatments were captured from medical prescription and …